Skip to main content
    I

    ImageneBio, Inc. (IMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.20
    -0.27 (-7.78%)

    Market Cap: $43.22M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    ImageneBio, Inc. (IMA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to ImageneBio are INmune Bio (INMB), iBio, Inc. Common Stock (IBIO) and Instil Bio (TIL). By market cap, ImageneBio ranks 6th of the 13 companies on this page; Immunic (IMUX) is the largest at $102.61M.

    Peer Comparison

    IMA's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    ImageneBio (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    Instil Bio Inc. (TIL)$41.23MN/AN/A0.0%-11.9%0.0%0.00%
    Connect Biopharma Holdings Ltd (CNTB)$42.65MN/A13.6x0.0%N/A5667.0%0.00%
    Biomea Fusion Inc (BMEA)$42.31MN/AN/A0.0%N/A0.0%0.00%
    Gossamer Bio Inc (GOSS)$67.10MN/A0.9x-159.5%147.4%189.1%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    Barinthus Biotherapeutics plc (BRNS)$30.23MN/AN/A0.0%N/A-100.0%0.00%
    Immunic Inc (IMUX)$102.61MN/AN/A0.0%N/A0.0%0.00%
    Estrella Immunopharma Inc. (ESLA)$22.36MN/AN/A0.0%N/A0.0%0.00%
    Edesa Biotech Inc (EDSA)$26.21MN/AN/A0.0%N/A-99.9%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    Peer median$42.48MN/A124.9x0.0%67.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to ImageneBio, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    iBio, Inc. Common Stock (IBIO)
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors
    Instil Bio Inc. (TIL)
    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients.
    TIL competitors
    Connect Biopharma Holdings Ltd (CNTB)
    Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators...
    CNTB competitors
    Biomea Fusion Inc (BMEA)
    Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat...
    BMEA competitors
    Gossamer Bio Inc (GOSS)
    Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing...
    GOSS competitors
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    Barinthus Biotherapeutics plc (BRNS)
    Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system...
    BRNS competitors
    Immunic Inc (IMUX)
    Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune...
    IMUX competitors
    Estrella Immunopharma Inc. (ESLA)
    Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
    ESLA competitors
    Edesa Biotech Inc (EDSA)
    Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development...
    EDSA competitors
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors

    Frequently Asked Questions About IMA

    Who are ImageneBio's main competitors?

    The companies most similar to ImageneBio include INmune Bio (INMB), iBio, Inc. Common Stock (IBIO), Instil Bio (TIL), Connect Biopharma Holdings (CNTB) and Biomea Fusion (BMEA), listed from the closest match.

    Who is ImageneBio's biggest competitor?

    Immunic (IMUX) is the largest of the similar companies at $102.61M; INmune Bio (INMB) is the closest match by business profile, size, sector and industry.

    How does IMA stock compare with its competitors?

    IMA's P/S is 68.5x against a peer median of 124.9x; its net margin is 0.0% against a peer median of 0.0%.

    Which of ImageneBio's competitors pays a higher dividend?

    ImageneBio pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is ImageneBio bigger than its competitors?

    No. ImageneBio is 6th by market cap among the 13 companies on this page; the largest is Immunic (IMUX) at $102.61M.